5/17/2022  5:35:10 PM Chg. +0.490 Volume Bid5/17/2022 Ask5:45:00 PM Market Capitalization Dividend Y. P/E Ratio
26.000EUR +1.92% 860,717
Turnover: 22.39 mill.
-Bid Size: - -Ask Size: - 12.18 bill.EUR 4.48% 16.34

Business description

Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

Management board & Supervisory board

Christian Kullmann
Management board
Ute Wolf, Dr. Harald Schwager, Thomas Wessel
Supervisory board
Bernd Tönjes, Edeltraud Glänzer, Angela Titzrath, Anke Strüber-Hummelt, Dr. Siegfried Luther, Dr. Thomas Sauer, Dr. Volker Trautz, Frank Löllgen, Hussin El Moussaoui, Jens Barnhusen, Karin Erhard, Martin Albers, Martin Kubessa, Martina Reisch, Michael Rüdiger, Peter Spuhler, Prof. Dr. Aldo Belloni, Prof. Dr. Barbara Grunewald, Professor Dr. Barbara Albert, Ulrich Weber

Company data

Name: Evonik Industries AG
Address: Rellinghauser Straße 1-11,D-45128 Essen
Phone: +49-201-177-01
Fax: +49-201-177-3475
E-mail: info@evonik.com
Internet: corporate.evonik.de/
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 12/31
Free Float: 25.98%
IPO date: -

Investor relations

Name: Tim Lange
IR phone: +49-201-177-3150
IR Fax: +49-201-177-3140
IR e-mail: -

Company calendar

CW 22 | 5/25/2022 General Shareholder Meeting
CW 32 | 8/3/2022 Interim Report 2nd Quarter/6 Months
CW 46 | 11/8/2022 Interim Report 3rd Quarter/9 Months

Main Shareholders

BlackRock, Inc.
AVGP Limited